Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Eur J Endocrinol ; 145(3): 295-301, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11517010

ABSTRACT

There are close interactions between the adipocyte-derived hormone, leptin, and the anterior pituitary, especially the hypothalamic-pituitary-adrenal (HPA) axis. We investigated the relationship between the sympathetic adrenergic system and serum leptin levels, dependent on the function of anterior pituitary hormone axes, in 27 patients without a history of a hormone-secreting pituitary adenoma or other underlying endocrine disease. Based on responses in a routine insulin hypoglycemia test (ITT), the patients were classified as hypopituitary (HP; n=15), growth hormone deficient (GHD; n=6) or controls (CTR; 6 patients with normal responses). Nadir plasma glucose was 1.5+/-0.1 mmol/l at the time of maximum hypoglycemia. Each group had a significant increase in plasma epinephrine; however the magnitude of change was significantly higher in GHD (6.066+/-1.633 nmol/l) compared with HP patients (1.781+/-0.492 nmol/l) (P<0.01). The rise in norepinephrine was delayed (60 min) in the HP and CTR groups. However, in GHD patients there was a considerable increase at the time of hypoglycemia which was significantly different from HP (P<0.001) and CTR (P<0.05) patients. The increase in catecholamines was followed by a quick and significant decrease in serum leptin levels 45 min after an i.v. bolus injection of insulin in HP patients (-4.7+/-2.5%, P<0.05), which was significantly sustained after 60 min (-5.6+/-2.5%, P<0.05). In CTR patients there was a significant decrease in serum leptin levels 60 min after i.v. insulin (-14.4+/-6.9%, P<0.05), while no significant response was observed in the GHD group, although 5 of 6 patients had decreased levels at 45 and 60 min. No differences between the groups were found by ANOVA. In conclusion, an acute increase in endogenous circulating catecholamines is associated with a quick decrease in serum leptin levels. Intact anterior pituitary function seems not to be essential for this hitherto poorly understood mechanism.


Subject(s)
Leptin/analysis , Pituitary Diseases/physiopathology , Pituitary Gland, Anterior/physiopathology , Adrenocorticotropic Hormone/blood , Adult , Blood Glucose/analysis , Body Mass Index , Epinephrine/blood , Female , Human Growth Hormone/blood , Human Growth Hormone/deficiency , Humans , Hydrocortisone/blood , Hypopituitarism/physiopathology , Insulin , Insulin-Like Growth Factor I/analysis , Kinetics , Male , Middle Aged , Norepinephrine/blood
2.
J Endocrinol Invest ; 23(6): 349-55, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10908161

ABSTRACT

Cushing's syndrome (CS) is associated with weight gain and visceral obesity. We examined the relationship between regional fat distribution and serum levels of leptin, cortisol and insulin. Twenty-three consecutive patients with recently diagnosed CS (18 with pituitary adenoma, 5 with adrenal tumor), where compared to obese controls, matched for age, sex and Body Mass Index (BMI). Serum insulin, leptin, cortisol, C-peptide and body composition determined by DEXA were measured. Serum leptin levels were significantly increased in patients with CS (36.9+/-3.8 vs 18.9+/-2.4 ng/ml, p<0.001; women: 40.1+/-4.6 vs 21.7+/-2.9 ng/ml, p<0.01; men: 27.9+/-5.7 vs 10.9+/-2.3 ng/ml; p<0.05), the same were fasting insulin levels (178+/-30 vs 81+/-10 pmol/l; p<0.01) and C-peptide (1.51+/-0.12 vs 0.77+/-0.07 nmol/l; p<0.001). In a subgroup of 12 patients, truncal fat mass was significantly elevated when compared to obese controls (19.2 kg vs 14.7 kg, p<0.01, and 42% vs 36% in percentage of truncal body tissue, p<0.05), whereas total fat mass was insignificantly increased. Serum leptin correlated positively to total body fat (%) as in patients with CS (r=0.94, p<0.001) as in controls (r=0.68, p<0.01). The correlation to truncal body fat (%) was also significant in both groups (CS: r=0.84, p<0.001; controls: r=0.63, p<0.01). Multiple regression showed that percent total body fat was the predictor of leptin concentrations among patients with CS (r2=0.88, p<0.001) whereas insulin did not contribute significantly to the variance in leptin concentrations. In controls, both leptin and insulin (r2=0.65, p<0.001) contributed significantly to the variations in leptin levels. Controlled for the differences in total body fat, patients with endogenous CS have significantly increased serum leptin levels, compared to BMI-matched obese controls. This suggests that hyperleptinemia in CS not primarily reflects changes in body composition, but is the result of different hormonal influences on adipose tissue.


Subject(s)
Body Composition , Body Mass Index , Cushing Syndrome/blood , Cushing Syndrome/pathology , Insulin/blood , Leptin/blood , Adipose Tissue/pathology , Adult , C-Peptide/blood , Fasting/blood , Female , Humans , Hydrocortisone/blood , Male , Osmolar Concentration , Reference Values
3.
Chemotherapy ; 37(5): 346-52, 1991.
Article in English | MEDLINE | ID: mdl-1804595

ABSTRACT

The efficacy and safety of the two antibiotic combinations, ceftazidime plus amikacin and ceftriaxone plus amikacin were compared in an open randomized trial. 100 episodes of neutropenia caused by malignant diseases and/or cytostatic drugs were evaluated in 66 males and 34 females with a mean age of 49.4 years. The types of infections treated were: septicemia 38, fever of undetermined origin 26, pneumonia 13, ear, nose and throat infections 11 and others 12. 17 episodes were not evaluable (6 protocol violations, 6 doubtful infections and 5 non-bacterial infections). The overall results were comparable, with a 74% success rate for ceftazidime and a 70% rate for ceftriaxone (criteria of the European Organization for Research and Treatment of Cancer). In the patients with septicemia, the success rate was 64% in the ceftriaxone and 57% in the ceftazidime group. Eight patients died during the treatment, in 5 cases due to infectious complications. There were no differences between the two groups in respect of efficacy or toxicity.


Subject(s)
Agranulocytosis/complications , Amikacin/therapeutic use , Bacterial Infections/drug therapy , Ceftazidime/therapeutic use , Ceftriaxone/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Agranulocytosis/chemically induced , Amikacin/administration & dosage , Ceftazidime/administration & dosage , Ceftriaxone/administration & dosage , Drug Therapy, Combination/therapeutic use , Female , Fever/chemically induced , Fever/complications , Humans , Leukemia/complications , Male , Middle Aged , Neoplasms/complications
4.
Schweiz Med Wochenschr ; 119(22): 796-802, 1989 Jun 03.
Article in German | MEDLINE | ID: mdl-2762789

ABSTRACT

Amborum Special F and ASFO are two names of a herbal remedy which is adulterated with the glucocorticoid betamethasone. Patients with asthma, rheumatic and chronic diseases import the drug direct from Burbank, California, USA. Its impressive antiasthmatic effect is reported in two patients. While under therapy the first patient developed Cushing's syndrome and the second showed suppression of adrenal cortisol production. The manufacturer, who claims that the drug contains no "western medicine" and in particular no cortisone, is unscrupulous enough to recommend it for children under two years of age. We have observed that a marked glucocorticoid effect and marked glucocorticoid side effects are achieved with small doses of betamethasone. A review of the literature and the two cases reported here suggest that the equivalence doses given in textbooks and tables of glucocorticoid equipotency are incorrect for betamethasone. Betamethasone is a more potent glucocorticoid than hitherto reported.


Subject(s)
Asthma/drug therapy , Betamethasone/administration & dosage , Phytotherapy , Plant Extracts/administration & dosage , Adult , Betamethasone/adverse effects , Child , Cushing Syndrome/chemically induced , Female , Humans , Hydrocortisone/antagonists & inhibitors , Male , Plant Extracts/adverse effects
5.
Schweiz Med Wochenschr ; 117(46): 1828-31, 1987 Nov 14.
Article in German | MEDLINE | ID: mdl-3122319

ABSTRACT

In this paper the case of a man with haemophilia A is presented. At the age of 18 years an acute lymphatic leukaemia was observed. The case report demonstrates that even in the presence of a severe plasmatic coagulopathy an acute lymphatic leukaemia can be successfully treated with intensive chemotherapy, if the monitoring of the coagulation values and the substitution of antihaemophilic globulin and thrombocytes are guaranteed. Only 4 cases of haemophilia and acute leukaemia in the same patient are described in the literature. So we believe that the association of these two rare disorders is merely accidental.


Subject(s)
Hemophilia A/complications , Leukemia, Lymphoid/complications , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Blood Coagulation Tests , Factor VIII/administration & dosage , Hemophilia A/therapy , Humans , Leukemia, Lymphoid/diagnosis , Leukemia, Lymphoid/drug therapy , Male
6.
Gastroenterology ; 93(4): 719-26, 1987 Oct.
Article in English | MEDLINE | ID: mdl-3623018

ABSTRACT

The intact cell hypothesis states that a reduced number of intrinsically normal hepatocytes, together with hemodynamic alterations, explains decreased drug metabolism in cirrhosis. We explored this hypothesis by comparing results of the aminopyrine breath test with in vitro measurements of aminopyrine N-demethylation and morphometrically determined liver cell volume in a rat model of cirrhosis. Aminopyrine N-demethylation in vivo (ABT-k) was 0.98 +/- 0.10/h (mean +/- SD) in controls. The cirrhotic rats were separated into those with normal (NCR) and those with abnormal ABT-k (PCR). Microsomal aminopyrine N-demethylase averaged 2.08 +/- 0.77 and 2.09 +/- 0.54 mumol/min in controls and NCRs, respectively; it was reduced to 1.00 +/- 0.81 mumol/min (p less than 0.02) in PCRs. Morphometrically determined hepatocellular volume was 18.8 +/- 2.8, 17.1 +/- 1.9, and 11.6 +/- 6.1 ml in controls, NCRs, and PCRs, respectively, PCRs being lower than controls (p less than 0.01) and NCRs (p less than 0.05). When N-demethylase and cytochrome P450 were related to hepatocellular volume (in milliliters), no significant difference between the three groups was apparent. We conclude that reduced aminopyrine N-demethylation in progressed cirrhosis is mainly due to a loss of liver cell volume. The function per liver cell volume remains constant, however, thus favoring the intact cell hypothesis for the handling of slowly metabolized compounds such as aminopyrine.


Subject(s)
Aminopyrine N-Demethylase/metabolism , Aminopyrine/metabolism , Liver Cirrhosis, Experimental/enzymology , Animals , Body Weight , Breath Tests , Disease Models, Animal , Male , Microsomes, Liver/enzymology , Organ Size , Rats , Rats, Inbred Strains
7.
Schweiz Med Wochenschr ; 117(41): 1596-7, 1987 Oct 10.
Article in German | MEDLINE | ID: mdl-3118459

ABSTRACT

Non-cavernous bacillary tuberculosis is observed with relatively increasing frequency nowadays. Most patients affected have very few or no symptoms, and radiographs usually show circumscribed lesions. The essential feature is the low infection risk due to the small number of bacilli excreted.


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Pulmonary/microbiology , Female , Humans , Male , Radiography , Sputum/microbiology , Tuberculosis, Pulmonary/diagnostic imaging
8.
Pathol Res Pract ; 166(1): 123-30, 1979 Dec.
Article in English | MEDLINE | ID: mdl-551398

ABSTRACT

A case of ameloblastic fibroma, and one of its more aggressive variety, the ameloblastic "fibrosarcoma", are presented. The clinical and morphologic differences are discussed. In our opinion, ameloblastic "fibrosarcoma" is a semimalignant tumor. Therefore we propose "proliferating ameloblastic fibroma" as a more appropriate designation.


Subject(s)
Odontogenic Tumors/pathology , Adolescent , Adult , Female , Humans , Male , Mandibular Neoplasms/pathology , Maxillary Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...